$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats 원문보기

Journal of pharmacy and pharmacology, v.63 no.6, 2011년, pp.817 - 824  

Tønsberg, Henrik (Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark) ,  Holm, René (Department of Preformulation, H.Lundbeck A) ,  Mu, Huiling (Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark) ,  Boll, Jette Bisgaard (Department of Preformulation, H.Lundbeck A) ,  Jacobsen, Jette (Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark) ,  Müllertz, Anette (Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark)

Abstract AI-Helper 아이콘AI-Helper

AbstractObjectivesThe aim of this study was to examine the effects of bile on the oral absorption of the poorly water-soluble compound, halofantrine, when administered to rats in vehicles consisting of the co-solvent polyethylene glycol 400 (PEG 400) alone or in mixtures with the surfactant polysorb...

참고문헌 (46)

  1. Transplant Proc Holt 26 2935 1994 The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine 

  2. J Pharm Pharmacol Perez de la Cruz Moreno 58 1079 2006 10.1211/jpp.58.8.0009 Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum 

  3. Pharm Res Persson 22 2141 2005 10.1007/s11095-005-8192-x The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids 

  4. J Pharm Sci Brouwers 95 372 2006 10.1002/jps.20553 Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir 

  5. J Pharm Sci Clarysse 98 1177 2009 10.1002/jps.21502 Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states 

  6. Pharm Res Kalantzi 23 165 2006 10.1007/s11095-005-8476-1 Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies 

  7. Pharm Res Strickley 21 201 2004 10.1023/B:PHAM.0000016235.32639.23 Solubilizing excipients in oral and injectable formulations 

  8. J Pharm Sci Tejwani 89 946 2000 10.1002/1520-6017(200007)89:7<946::AID-JPS12>3.0.CO;2-2 Study of phase behavior of poly(ethylene glycol)-polysorbate 80 and poly(ethylene glycol)-polysorbate 80-water mixtures 

  9. Chem Pharm Bull Amemiya 46 309 1998 10.1248/cpb.46.309 Development of emulsion type new vehicle for soft gelatin capsule. I. Selection of surfactants for development of new vehicle and its physicochemical properties 

  10. J Pharm Sci Yalkowsky 72 1014 1983 10.1002/jps.2600720911 In vitro method for detecting precipitation of parenteral formulations after injection 

  11. Drug Intell Clin Pharm Yalkowsky 11 417 1977 10.1177/106002807701100703 Precipitation of solubilized drugs due to injection or dilution 

  12. Drug Dev Ind Pharm Gao 30 221 2004 10.1081/DDC-120028718 Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations 

  13. J Pharm Sci Gao 92 2386 2003 10.1002/jps.10511 Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability 

  14. Int J Pharm Dai 393 1 2010 10.1016/j.ijpharm.2010.03.040 In vitro methods to assess drug precipitation 

  15. J Pharm Sci Dai 96 2957 2007 10.1002/jps.20886 Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME) 

  16. Pharm Res Carlert 27 2119 2010 10.1007/s11095-010-0213-8 Predicting intestinal precipitation - a case example for a basic BCS class II drug 

  17. J Pharm Pharmacol Tønsberg 62 63 2010 10.1211/jpp.62.01.0006 Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats 

  18. Lab Anim Tønsberg 44 373 2010 10.1258/la.2010.010010 An updated and simplified method for bile duct cannulation of rats 

  19. Pharm Res Karpf 21 1413 2004 10.1023/B:PHAM.0000036915.03725.19 Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats 

  20. J Pharm Biomed Anal Humberstone 13 265 1995 10.1016/0731-7085(95)01256-K A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions 

  21. J Chromatogr B Scalia 431 259 1988 10.1016/S0378-4347(00)83095-9 Simultaneous determination of free and conjugated bile-acids in human gastric-juice by high-performance liquid-chromatography 

  22. J Chromatogr B Lee 704 35 1997 10.1016/S0378-4347(97)00443-X Comparative analysis of conjugated bile acids in human serum using high-performance liquid chromatography and capillary electrophoresis 

  23. J Lipid Res Persson 48 242 2007 10.1194/jlr.D600035-JLR200 Simultaneous assessment of lipid classes and bile acids in human intestinal fluid by solid-phase extraction and HPLC methods 

  24. Int J Pharm De Smidt 270 109 2004 10.1016/j.ijpharm.2003.10.036 Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility 

  25. Int J Pharm Liu 118 55 1995 10.1016/0378-5173(94)00336-4 Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane 

  26. Applications of Surface Active Compounds - Vol III of Chemistry, Physics and Application of Surface Active Substances Treon 381 1967 

  27. Pharm Res Larsen 25 2769 2008 10.1007/s11095-008-9641-0 Lipid-based formulations for danazol containing a digestible surfactant, labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis 

  28. J Pharm Sci Cuine 97 995 2008 10.1002/jps.21246 Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs 

  29. Hepatology Hofmann 49 1403 2009 10.1002/hep.22789 Bile acids: trying to understand their chemistry and biology with the hope of helping patients 

  30. World J Gastroenterol Monte 15 804 2009 10.3748/wjg.15.804 Bile acids: chemistry, physiology, and pathophysiology 

  31. Pharm Res Trevaskis 22 1863 2005 10.1007/s11095-005-6808-9 Bile increases intestinal lymphatic drug transport in the fasted rat 

  32. Res Commun Mol Pathol Pharmacol Kim 104 107 1999 Enhanced absorption of oral furosemide by bile juice in rats 

  33. Pharm Acta Helv Rowbotham 15 304 1976 Some aspects of the photochemical degradation of frusemide 

  34. Int J Pharm Devarakonda 345 142 2007 10.1016/j.ijpharm.2007.05.039 Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes 

  35. Boll Soc Ital Biol Sper Croce 49 653 1973 [Changes in choleresis in rats induced with some solvents and vehicles of drugs] 

  36. Pharm Res Seeballuck 20 1085 2003 10.1023/A:1024422625596 The effects of Pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells 

  37. Pharm Res Seeballuck 21 2320 2004 10.1007/s11095-004-7684-4 Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model 

  38. Eur J Pharm Sci Lind 35 211 2008 10.1016/j.ejps.2008.07.003 Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80 

  39. Int J Pharm Holm 272 189 2004 10.1016/j.ijpharm.2003.12.017 Successful in silico predicting of intestinal lymphatic transfer 

  40. Comp Biochem Physiol Alvaro 83B 551 1986 Relationships between bile salts hydrophilicity and phospholipid composition in bile of various animal species 

  41. J Lipid Res Hagio 50 173 2009 10.1194/jlr.D800041-JLR200 Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS 

  42. Pharmacol Toxicol Farkas 68 154 1991 10.1111/j.1600-0773.1991.tb02057.x Polysorbate toxicity in neonatal rats and mice 

  43. Bull Sch Med Univ Krantz 97 48 1949 Toxicologic, pharmacodynamic and clinical observations on Tween 80 

  44. Pharm Res Swenson 11 1132 1994 10.1023/A:1018984731584 Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility 

  45. Topics Pharm Sci Curatolo 91 189 1992 Permeability enhancers for oral dosing: efficacy and potential toxicity 

  46. Drug Metab Pharmacokinet Araya 20 257 2005 10.2133/dmpk.20.257 The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion II: stable gastrointestinal absorption of a poorly water soluble new compound, ER-1258 in bile-fistula rats 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로